TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotech-IgG Equity AB (publ)
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 8,207 | 4,025 | 14,569 |
Financial expenses | 2,748 | 392 | 676 |
Earnings before taxes | -57,360 | 1,633 | -3,344 |
EBITDA | 639 | -495 | -2,634 |
Total assets | 59,844 | 126,761 | 6,736 |
Current assets | 18,895 | 12,057 | 6,234 |
Current liabilities | 20,530 | 33,046 | 2,040 |
Equity capital | 36,838 | 93,715 | 3,843 |
- share capital | 50,917 | 50,629 | 6,219 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 61.6% | 73.9% | 57.1% |
Turnover per employee | 4,104 | 2,012 | 7,284 |
Profit as a percentage of turnover | -698.9% | 40.6% | -23.0% |
Return on assets (ROA) | -91.3% | 1.6% | -39.6% |
Current ratio | 92.0% | 36.5% | 305.6% |
Return on equity (ROE) | -155.7% | 1.7% | -87.0% |
Change turnover | 4,508 | -10,268 | -14,595 |
Change turnover % | 122% | -72% | -50% |
Chg. No. of employees | 0 | 0 | -1 |
Chg. No. of employees % | 0% | 0% | -33% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.